{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,15]],"date-time":"2026-10-15T23:54:55Z","timestamp":1792108495534,"version":"4.4.0"},"reference-count":151,"publisher":"Elsevier BV","issue":"1","license":[{"start":{"date-parts":[[2022,1,1]],"date-time":"2022-01-01T00:00:00Z","timestamp":1640995200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2022,1,1]],"date-time":"2022-01-01T00:00:00Z","timestamp":1640995200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2021,12,21]],"date-time":"2021-12-21T00:00:00Z","timestamp":1640044800000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/100000049","name":"national institute on aging","doi-asserted-by":"publisher","award":["AG041718"],"award-info":[{"award-number":["AG041718"]}],"id":[{"id":"10.13039\/100000049","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000049","name":"national institute on aging","doi-asserted-by":"publisher","award":["AG030653"],"award-info":[{"award-number":["AG030653"]}],"id":[{"id":"10.13039\/100000049","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000049","name":"national institute on aging","doi-asserted-by":"publisher","award":["AG064877"],"award-info":[{"award-number":["AG064877"]}],"id":[{"id":"10.13039\/100000049","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000049","name":"national institute on aging","doi-asserted-by":"publisher","award":["P30-AG066468"],"award-info":[{"award-number":["P30-AG066468"]}],"id":[{"id":"10.13039\/100000049","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["neurotherapeuticsjournal.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Neurotherapeutics"],"published-print":{"date-parts":[[2022,1]]},"DOI":"10.1007\/s13311-021-01152-0","type":"journal-article","created":{"date-parts":[[2021,12,21]],"date-time":"2021-12-21T13:58:54Z","timestamp":1640095134000},"page":"152-172","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":64,"title":["Genomics and Functional Genomics of Alzheimer's Disease"],"prefix":"10.1016","volume":"19","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-3453-1438","authenticated-orcid":false,"given":"M. Ilyas","family":"Kamboh","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1007\/s13311-021-01152-0_bib1","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.jalz.2011.10.007","article-title":"National Institute on Aging\u2013Alzheimer's Association guidelines for the neuropathologic assessment of Alzheimer's disease","volume":"8","author":"Hyman","year":"2012","journal-title":"Alzheimers Dement"},{"key":"10.1007\/s13311-021-01152-0_bib2","doi-asserted-by":"crossref","first-page":"327","DOI":"10.1002\/alz.12328","volume":"17","author":"Alzheimer's disease facts and figures","year":"2021","journal-title":"Alzheimers Dement"},{"key":"10.1007\/s13311-021-01152-0_bib3","unstructured":"Alzheimer's Disease International. World Alzheimer Report 2015 \u2013 updated in 2017."},{"key":"10.1007\/s13311-021-01152-0_bib4","doi-asserted-by":"crossref","first-page":"310","DOI":"10.1016\/j.jalz.2013.10.005","article-title":"Gender and incidence of dementia in the Framingham Heart Study from mid-adult life","volume":"11","author":"Chene","year":"2015","journal-title":"Alzheimers Dement"},{"key":"10.1007\/s13311-021-01152-0_bib5","doi-asserted-by":"crossref","first-page":"168","DOI":"10.1001\/archpsyc.63.2.168","article-title":"Role of genes and environments for explaining Alzheimer disease","volume":"63","author":"Gatz","year":"2006","journal-title":"Arch Gen Psychiatry"},{"key":"10.1007\/s13311-021-01152-0_bib6","doi-asserted-by":"crossref","first-page":"59","DOI":"10.1001\/archneurol.2011.221","article-title":"Autosomal recessive causes likely in early-onset Alzheimer disease","volume":"69","author":"Wingo","year":"2012","journal-title":"Arch Neurol"},{"key":"10.1007\/s13311-021-01152-0_bib7","doi-asserted-by":"crossref","first-page":"381","DOI":"10.1046\/j.1529-8817.2004.00110.x","article-title":"Molecular genetics of late-onset Alzheimer's disease","volume":"68","author":"Kamboh","year":"2004","journal-title":"Ann Human Genet"},{"key":"10.1007\/s13311-021-01152-0_bib8","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1038\/ng1934","article-title":"Systematic meta-analyses of Alzheimer disease genetic association studies: the AlzGene database","volume":"39","author":"Bertram","year":"2007","journal-title":"Nat Genet"},{"key":"10.1007\/s13311-021-01152-0_bib9","first-page":"e13","article-title":"Assessment of the genetic variance of late-onset Alzheimer's disease","volume":"200","author":"Ridge","year":"2016","journal-title":"Neurobiol Aging"},{"key":"10.1007\/s13311-021-01152-0_bib10","doi-asserted-by":"crossref","unstructured":"Lee S, Harold D, Nyholt DR, ANZGene Consortium, International Endogene Consortium, Genetic and Environmental Risk for Alzheimer's disease Consortium, et al. Estimation and partitioning of polygenic variation captured by common SNPs for Alzheimer's disease, multiple sclerosis and endometriosis. Hum Mol Genet 2013; 22: 832\u2013841.","DOI":"10.1093\/hmg\/dds491"},{"key":"10.1007\/s13311-021-01152-0_bib11","unstructured":"Brainstorm Consortium et al. Analysis of shared heritability in common disorders of the brain. Science 2018; 360: eaap8757."},{"issue":"367","key":"10.1007\/s13311-021-01152-0_bib12","first-page":"780","article-title":"367:795\u2013804","volume":"2012","author":"Bateman","year":"2012","journal-title":"Erratum. In: N Engl J Med"},{"key":"10.1007\/s13311-021-01152-0_bib13","doi-asserted-by":"crossref","first-page":"241","DOI":"10.1016\/S1474-4422(18)30028-0","article-title":"Spatial patterns of neuroimaging biomarker change in individuals from families with autosomal dominant Alzheimer's disease: a longitudinal study","volume":"17","author":"Gordan","year":"2018","journal-title":"Lancet Neurol"},{"key":"10.1007\/s13311-021-01152-0_bib14","doi-asserted-by":"crossref","first-page":"535","DOI":"10.1016\/j.jalz.2018.02.018","article-title":"NIA-AA Research Framework: Toward a biological definition of Alzheimer's disease","volume":"14","author":"Jack","year":"2018","journal-title":"Alzheimers Dement"},{"key":"10.1007\/s13311-021-01152-0_bib15","first-page":"38","article-title":"Rate of early onset Alzheimer's disease: a systematic review and meta-analysis","volume":"3","author":"Zhu","year":"2015","journal-title":"Ann Transl Med"},{"key":"10.1007\/s13311-021-01152-0_bib16","doi-asserted-by":"crossref","first-page":"733","DOI":"10.1016\/j.jalz.2016.01.012","article-title":"Molecular genetics of early-onset Alzheimer's disease revisited","volume":"12","author":"Cacace","year":"2016","journal-title":"Alzheimers Dement"},{"key":"10.1007\/s13311-021-01152-0_bib17","doi-asserted-by":"crossref","first-page":"299","DOI":"10.1177\/1533317514545825","article-title":"The patterns of inheritance in early-onset dementia: Alzheimer's disease and frontotemporal dementia","volume":"30","author":"Jarmolowicz","year":"2015","journal-title":"Am J Alzheimers Dis Other Demen"},{"key":"10.1007\/s13311-021-01152-0_bib18","doi-asserted-by":"crossref","unstructured":"De Strooper, B. Vassar R, Golde T. The secretases: enzymes with therapeutic potential in Alzheimer disease. Nat Rev Neurol 2010; 6:99\u2013107.","DOI":"10.1038\/nrneurol.2009.218"},{"key":"10.1007\/s13311-021-01152-0_bib19","doi-asserted-by":"crossref","unstructured":"Zhou R, Yang G, Guo X, Zhou Q, Lei J, Shi Y. Recognition of the amyloid precursor protein by human \u03b3-secretase. Science 2019; 363:eaaw0930","DOI":"10.1126\/science.aaw0930"},{"key":"10.1007\/s13311-021-01152-0_bib20","doi-asserted-by":"crossref","first-page":"162","DOI":"10.1016\/j.neulet.2019.02.011","article-title":"\u03b3-Secretase and its modulators: Twenty years and beyond","volume":"701","author":"Xia","year":"2019","journal-title":"Neurosci Lett"},{"key":"10.1007\/s13311-021-01152-0_bib21","doi-asserted-by":"crossref","first-page":"435","DOI":"10.1016\/j.cell.2005.05.022","article-title":"Nicastrin functions as a gamma-secretase substrate receptor","volume":"122","author":"Shah","year":"2005","journal-title":"Cell"},{"key":"10.1007\/s13311-021-01152-0_bib22","doi-asserted-by":"crossref","unstructured":"Wong E, Frost GR, Li YM. \u03b3-secretase modulatory proteins: The guiding hand behind the running scissors Front Aging Neurosci. 2020; 12:614690.","DOI":"10.3389\/fnagi.2020.614690"},{"key":"10.1007\/s13311-021-01152-0_bib23","doi-asserted-by":"crossref","unstructured":"Hoogmartens J, Cacace R, Van Broeckhoven C. Insight into the genetic etiology of Alzheimer's disease: A comprehensive review of the role of rare variants. Alzheimers Dement (Amst). 2021; 13:e12155.","DOI":"10.1002\/dad2.12155"},{"key":"10.1007\/s13311-021-01152-0_bib24","doi-asserted-by":"crossref","unstructured":"Tcw J, Goate AH. Genetics of \u03b2-amyloid precursor protein in Alzheimer's disease. Cold Spring Harb Perspect Med 2017; 7:a024539.","DOI":"10.1101\/cshperspect.a024539"},{"key":"10.1007\/s13311-021-01152-0_bib25","doi-asserted-by":"crossref","first-page":"595","DOI":"10.15252\/emmm.201606210","article-title":"The amyloid hypothesis of Alzheimer's disease at 25 years","volume":"8","author":"Selkoe","year":"2016","journal-title":"EMBO Mol Med"},{"key":"10.1007\/s13311-021-01152-0_bib26","doi-asserted-by":"crossref","first-page":"E476","DOI":"10.1073\/pnas.1618657114","article-title":"Analysis of 138 PSEN1 pathogenic mutations in the presenilin-1 on the in vitro production of A\u03b242 and A\u03b240 peptides by \u03b3-secretase","volume":"114","author":"Sun","year":"2017","journal-title":"Proc Natl Acad Sci USA"},{"key":"10.1007\/s13311-021-01152-0_bib27","doi-asserted-by":"crossref","first-page":"875","DOI":"10.1038\/mp.2012.15","article-title":"High frequency of potentially pathogenic SORL1 mutations in autosomal dominant early onset Alzheimer disease","volume":"17","author":"Pottier","year":"2012","journal-title":"Mol Psychiatry"},{"key":"10.1007\/s13311-021-01152-0_bib28","doi-asserted-by":"crossref","first-page":"831","DOI":"10.1038\/mp.2015.121","article-title":"SORL1 rare variants: a major risk factor for familial early-onset Alzheimer's disease","volume":"21","author":"Nicolas","year":"2016","journal-title":"Mol Psychiatry"},{"key":"10.1007\/s13311-021-01152-0_bib29","doi-asserted-by":"crossref","first-page":"3987","DOI":"10.1093\/hmg\/ddp323","article-title":"Potential late-onset Alzheimer disease associated mutations in the ADAM10 gene attenuate alpha-secretase activity","volume":"18","author":"Kim","year":"2009","journal-title":"Hum Mol Genet"},{"key":"10.1007\/s13311-021-01152-0_bib30","doi-asserted-by":"crossref","first-page":"385","DOI":"10.1016\/j.neuron.2013.08.035","article-title":"ADAM10 missense mutations potentiate \u03b2-amyloid accumulation by impairing prodomain chaperone function","volume":"80","author":"Shu","year":"2013","journal-title":"Neuron"},{"key":"10.1007\/s13311-021-01152-0_bib31","doi-asserted-by":"crossref","unstructured":"Cruchaga, C. Haller G, Chakraverty S, Mayo K, Vallania FL, Mitra RD, et al. Rare variants in APP, PSEN1 and PSEN2 increase risk for AD in late-onset Alzheimer's disease families. PLoS ONE 2012; 7:e31039.","DOI":"10.1371\/journal.pone.0031039"},{"key":"10.1007\/s13311-021-01152-0_bib32","doi-asserted-by":"crossref","first-page":"96","DOI":"10.1038\/nature11283","article-title":"A mutation in APP protects against Alzheimer's disease and age-related cognitive decline","volume":"488","author":"Jonsson","year":"2012","journal-title":"Nature"},{"key":"10.1007\/s13311-021-01152-0_bib33","doi-asserted-by":"crossref","first-page":"1779.e1715","DOI":"10.1016\/j.neurobiolaging.2014.01.020","article-title":"Investigation of an amyloid precursor protein protective mutation (A673T) in a North American case-control sample of late-onset Alzheimer's disease","volume":"35","author":"Bamne","year":"2014","journal-title":"Neurobiol Aging"},{"key":"10.1007\/s13311-021-01152-0_bib34","doi-asserted-by":"crossref","first-page":"209","DOI":"10.1001\/jamaneurol.2014.2157","article-title":"Rarity of the Alzheimer disease-protective APP A673T variant in the United States","volume":"72","author":"Wang","year":"2015","journal-title":"JAMA Neurol"},{"key":"10.1007\/s13311-021-01152-0_bib35","doi-asserted-by":"crossref","first-page":"4038","DOI":"10.1007\/s12035-021-02385-y","article-title":"The Protective A673T mutation of amyloid precursor protein (APP) in Alzheimer's disease","volume":"58","author":"Xia","year":"2021","journal-title":"Mol Neurobiol"},{"key":"10.1007\/s13311-021-01152-0_bib36","doi-asserted-by":"crossref","first-page":"1518.e1511","DOI":"10.1016\/j.neurobiolaging.2012.09.017","article-title":"Amyloid precursor protein (APP) A673T mutation in the elderly Finnish population","volume":"34","author":"Kero","year":"2013","journal-title":"Neurobiol Aging"},{"key":"10.1007\/s13311-021-01152-0_bib37","first-page":"195","article-title":"Apolipoprotein E polymorphism and susceptibility to Alzheimer's diseases","volume":"67","author":"Kamboh","year":"1995","journal-title":"Hum Biol"},{"key":"10.1007\/s13311-021-01152-0_bib38","doi-asserted-by":"crossref","unstructured":"Farrer LA, Cupples L, Haines JL, Kukull WA, Mayeux R, Pericak-Vance MA, et al. Effects of age, sex, and ethnicity on the association between apolipoprotein E genotype and Alzheimer disease. A meta-analysis. APOE and Alzheimer Disease Meta Analysis Consortium. JAMA 1997; 278:1349\u20131356.","DOI":"10.1001\/jama.1997.03550160069041"},{"key":"10.1007\/s13311-021-01152-0_bib39","doi-asserted-by":"crossref","first-page":"496","DOI":"10.1111\/j.1469-1809.2006.00344.x","article-title":"The missing ApoE allele","volume":"71","author":"Seripa","year":"2007","journal-title":"Ann Hm Genet"},{"key":"10.1007\/s13311-021-01152-0_bib40","doi-asserted-by":"crossref","first-page":"739","DOI":"10.1007\/s00109-016-1427-y","article-title":"Apolipoprotein E: from cardiovascular disease to neurodegenerative disorders","volume":"94","author":"Mahley","year":"2016","journal-title":"J Mol Med (Berl)"},{"key":"10.1007\/s13311-021-01152-0_bib41","doi-asserted-by":"crossref","first-page":"165","DOI":"10.1016\/j.pathol.2018.11.002","article-title":"Apolipoprotein E in lipoprotein metabolism, health and cardiovascular disease","volume":"51","author":"Marais","year":"2019","journal-title":"Pathology"},{"key":"10.1007\/s13311-021-01152-0_bib42","doi-asserted-by":"crossref","unstructured":"Yamazaki Y, Zhao N, Caulfied TR, Liu C-C, Bu G. Apolipoprotein E and Alzheimer disease: pathobiology and targeting strategies. Nat Rev Neurol 2019; 15:501\u2013518.","DOI":"10.1038\/s41582-019-0228-7"},{"key":"10.1007\/s13311-021-01152-0_bib43","doi-asserted-by":"crossref","first-page":"312","DOI":"10.1016\/j.cell.2019.09.001","article-title":"Alzheimer Disease: An update on pathobiology and treatment strategies","volume":"179","author":"Long","year":"2019","journal-title":"Cell"},{"key":"10.1007\/s13311-021-01152-0_bib44","doi-asserted-by":"crossref","unstructured":"Lumsden AL, Mulugeta A, Zhou A, Hypp\u00f6nen E. Apolipoprotein E (APOE) genotype-associated disease risks: a phenome-wide, registry-based, case-control study utilising the UK Biobank. EBioMedicine 2020; 59:102954.","DOI":"10.1016\/j.ebiom.2020.102954"},{"key":"10.1007\/s13311-021-01152-0_bib45","doi-asserted-by":"crossref","first-page":"205","DOI":"10.1016\/j.neuron.2020.10.008","article-title":"Apolipoprotein E: Structural insights and links to Alzheimer disease pathogenesis","volume":"109","author":"Chen","year":"2021","journal-title":"Neuron"},{"key":"10.1007\/s13311-021-01152-0_bib46","doi-asserted-by":"crossref","first-page":"903","DOI":"10.1038\/mp.2011.52","article-title":"APOE and Alzheimer disease: a major gene with semi-dominant inheritance","volume":"16","author":"Genin","year":"2011","journal-title":"Mol Psychiatry"},{"key":"10.1007\/s13311-021-01152-0_bib47","doi-asserted-by":"crossref","first-page":"4383","DOI":"10.1038\/srep04383","article-title":"Apolipoprotein E gene polymorphism and Alzheimer's disease in Chinese population: a meta-analysis","volume":"4","author":"Liu","year":"2014","journal-title":"Sci Rep."},{"key":"10.1007\/s13311-021-01152-0_bib48","doi-asserted-by":"crossref","first-page":"21007791","DOI":"10.1371\/journal.pgen.1007791","article-title":"Ancestral origin of ApoE \u03b54 Alzheimer disease risk in Puerto Rican and African American populations","volume":"14","author":"Rajabli","year":"2018","journal-title":"PLoS Genet"},{"key":"10.1007\/s13311-021-01152-0_bib49","doi-asserted-by":"crossref","first-page":"129","DOI":"10.1016\/S0304-3940(99)00129-9","article-title":"A novel mutation in the apolipoprotein E gene (APOE*4 Pittsburgh) is associated with the risk of late-onset Alzheimer's disease","volume":"263","author":"Kamboh","year":"1999","journal-title":"Neurosci Lett"},{"key":"10.1007\/s13311-021-01152-0_bib50","doi-asserted-by":"crossref","unstructured":"Medway CW, Abdul-Hay S, Mims T, Ma L, Bisceglio G, Zou F, et al. ApoE variant p.V236E is associated with markedly reduced risk of Alzheimer's disease. Mol Neurodegener 2014; 9:11.","DOI":"10.1186\/1750-1326-9-11"},{"key":"10.1007\/s13311-021-01152-0_bib51","doi-asserted-by":"crossref","unstructured":"Blue EE, Cheng A, Chen S, Yu CE; Alzheimer's Disease Genetics Consortium. Association of uncommon, noncoding variants in the APOE region with risk of Alzheimer disease in adults of European ancestry JAMA Netw Open 2020; 3(10):e2017666.","DOI":"10.1001\/jamanetworkopen.2020.17666"},{"key":"10.1007\/s13311-021-01152-0_bib52","doi-asserted-by":"crossref","first-page":"865","DOI":"10.1093\/hmg\/ddm031","article-title":"Evidence for novel susceptibility genes for late-onset Alzheimer's disease from a genome-wide association study of putative functional variants","volume":"16","author":"Grupe","year":"2007","journal-title":"Hum Mol Genet"},{"key":"10.1007\/s13311-021-01152-0_bib53","doi-asserted-by":"crossref","first-page":"613","DOI":"10.4088\/JCP.v68n0419","article-title":"A high-density whole-genome association study reveals that APOE is the major susceptibility gene for sporadic late-onset Alzheimer's disease","volume":"68","author":"Coon","year":"2007","journal-title":"J Clin Psych"},{"key":"10.1007\/s13311-021-01152-0_bib54","doi-asserted-by":"crossref","first-page":"713","DOI":"10.1016\/j.neuron.2007.05.022","article-title":"GAB2 alleles modify Alzheimer's risk in APOE epsilon4 carriers","volume":"54","author":"Reiman","year":"2007","journal-title":"Neuron"},{"key":"10.1007\/s13311-021-01152-0_bib55","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1001\/archneurol.2007.3","article-title":"Candidate single-nucleotide polymorphisms from a genomewide association study of Alzheimer disease","volume":"65","author":"Li","year":"2008","journal-title":"Arch Neurol"},{"key":"10.1007\/s13311-021-01152-0_bib56","doi-asserted-by":"crossref","first-page":"623","DOI":"10.1016\/j.ajhg.2008.10.008","article-title":"Genome-wide association analysis reveals putative Alzheimer's disease susceptibility loci in addition to APOE","volume":"83","author":"Bertram","year":"2008","journal-title":"Am J Hum Genet"},{"key":"10.1007\/s13311-021-01152-0_bib57","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1016\/j.ajhg.2008.12.008","article-title":"Genome-wide association study implicates a chromosome 12 risk locus for late-onset Alzheimer disease","volume":"84","author":"Beecham","year":"2009","journal-title":"Am J Hum Genet"},{"key":"10.1007\/s13311-021-01152-0_bib58","doi-asserted-by":"crossref","first-page":"44","DOI":"10.1186\/1755-8794-1-44","article-title":"A genome-wide association study for late-onset Alzheimer's disease using DNA pooling","volume":"1","author":"Abraham","year":"2008","journal-title":"BMC Med Genomics"},{"key":"10.1007\/s13311-021-01152-0_bib59","doi-asserted-by":"crossref","first-page":"192","DOI":"10.1038\/ng.305","article-title":"Genetic variation in PCDH11X is associated with susceptibility to late-onset Alzheimer's disease","volume":"41","author":"Carrasquillo","year":"2009","journal-title":"Nat Genet"},{"key":"10.1007\/s13311-021-01152-0_bib60","doi-asserted-by":"crossref","first-page":"1088","DOI":"10.1038\/ng.440","article-title":"Genome-wide association study identifies variants at CLU and PICALM associated with Alzheimer's disease","volume":"41","author":"Harold","year":"2009","journal-title":"Nat Genet"},{"key":"10.1007\/s13311-021-01152-0_bib61","doi-asserted-by":"crossref","unstructured":"Lambert JC, Heath S, EvenG, Campion D, SleegersK, HiltunenM, et al. Genomewide association study identifies variants at CLU and CR1 associated with Alzheimer's disease. Nat Genet 2009; 41:1094\u20131099.","DOI":"10.1038\/ng.439"},{"key":"10.1007\/s13311-021-01152-0_bib62","doi-asserted-by":"crossref","first-page":"1832","DOI":"10.1001\/jama.2010.574","article-title":"Genome-wide association analysis of genetic loci associated with Alzheimer disease","volume":"303","author":"Seshadri","year":"2010","journal-title":"JAMA"},{"key":"10.1007\/s13311-021-01152-0_bib63","doi-asserted-by":"crossref","first-page":"429","DOI":"10.1038\/ng.803","article-title":"Common variants at ABCA7, MS4A6A\/MS4A4E, EPHA1, CD33 and CD2AP are associated with Alzheimer's disease","volume":"43","author":"Hollingworth","year":"2011","journal-title":"Nat Genet"},{"key":"10.1007\/s13311-021-01152-0_bib64","doi-asserted-by":"crossref","first-page":"436","DOI":"10.1038\/ng.801","article-title":"Common variants at MS4A4\/MS4A6E, CD2AP, CD33 and EPHA1 are associated with late-onset Alzheimer's disease","volume":"43","author":"Naj","year":"2011","journal-title":"Nat Genet"},{"key":"10.1007\/s13311-021-01152-0_bib65","doi-asserted-by":"crossref","first-page":"1452","DOI":"10.1038\/ng.2802","article-title":"Meta-analysis of 74,046 individuals identifies 11 new susceptibility loci for Alzheimer's disease","volume":"45","author":"Lambert","year":"2013","journal-title":"Nat Genet"},{"key":"10.1007\/s13311-021-01152-0_bib66","doi-asserted-by":"crossref","unstructured":"Kamboh MI, Demirci FY, Wang X, Minster RL, Carrasquillo MM, Pankratz VS, et al. Genome-wide association study of Alzheimer's disease. Transl Psychiatry 2012; 2:e117.","DOI":"10.1038\/tp.2012.45"},{"key":"10.1007\/s13311-021-01152-0_bib67","doi-asserted-by":"crossref","unstructured":"Jonsson T, Stefansson H, Steinberg,S. Jonsdottir I, Jonsson PV, Snaedal J, et al. Variant of TREM2 associated with the risk of Alzheimer's disease. N Engl J Med 2013; 368:107\u2013116.","DOI":"10.1056\/NEJMoa1211103"},{"key":"10.1007\/s13311-021-01152-0_bib68","doi-asserted-by":"crossref","unstructured":"Rosenthal SL, Bamne MN, Wang X, Berman S, Snitz BE, Klunk WE, et al. More evidence for association of a rare TREM2 mutation (R47H) with Alzheimer's disease risk. Neurobiol Aging 2015; 36:2443.e21e2443.e26.","DOI":"10.1016\/j.neurobiolaging.2015.04.012"},{"key":"10.1007\/s13311-021-01152-0_bib69","doi-asserted-by":"crossref","unstructured":"Ruiz A, Heilmann S, Becker T, Hernandez I, Wagner H, Thelen M, et al. Follow-up of loci from the International Genomics of Alzheimer's Disease Project identifies TRIP4 as a novel susceptibility gene. Transl Psychiatry 2014; 4:e358.","DOI":"10.1038\/tp.2014.2"},{"key":"10.1007\/s13311-021-01152-0_bib70","doi-asserted-by":"crossref","first-page":"1373","DOI":"10.1038\/ng.3916","article-title":"Rare coding variants in PLCG2, ABI3 and TREM2 implicate microglia-mediated innate immunity in Alzheimer's disease","volume":"49","author":"Sims","year":"2017","journal-title":"Nat Genet"},{"key":"10.1007\/s13311-021-01152-0_bib71","doi-asserted-by":"crossref","first-page":"325","DOI":"10.1038\/ng.3766","article-title":"Case-control association mapping by proxy using family history of disease","volume":"49","author":"Liu","year":"2017","journal-title":"Nat Genet"},{"key":"10.1007\/s13311-021-01152-0_bib72","doi-asserted-by":"crossref","first-page":"99","DOI":"10.1038\/s41398-018-0150-6","article-title":"GWAS on family history of Alzheimer's disease","volume":"8","author":"Marioni","year":"2018","journal-title":"Transl Psychiatry"},{"key":"10.1007\/s13311-021-01152-0_bib73","doi-asserted-by":"crossref","first-page":"404","DOI":"10.1038\/s41588-018-0311-9","article-title":"Genome-wide meta analysis identifies new loci and functional pathways influencing Alzheimer's disease risk","volume":"51","author":"Jansen","year":"2019","journal-title":"Nat Genet"},{"key":"10.1007\/s13311-021-01152-0_bib74","doi-asserted-by":"crossref","first-page":"414","DOI":"10.1038\/s41588-019-0358-2","article-title":"Genetic meta-analysis of diagnosed Alzheimer's disease identifies new risk loci and implicates A\u03b2, tau, immunity and lipid processing","volume":"51","author":"Kunkle","year":"2019","journal-title":"Nat Genet"},{"key":"10.1007\/s13311-021-01152-0_bib75","doi-asserted-by":"crossref","first-page":"392","DOI":"10.1038\/s41588-020-00776-w","article-title":"Genome-wide meta-analysis, fine-mapping and integrative prioritization implicate new Alzheimer's disease risk genes","volume":"53","author":"Schwartzentruber","year":"2021","journal-title":"Nat Genet"},{"key":"10.1007\/s13311-021-01152-0_bib76","doi-asserted-by":"crossref","first-page":"1276","DOI":"10.1038\/s41588-021-00921-z","article-title":"A genome-wide association study with 1,126,563 individuals identifies new risk loci for Alzheimer's disease","volume":"53","author":"Wightman","year":"2021","journal-title":"Nat Genet"},{"key":"10.1007\/s13311-021-01152-0_bib77","doi-asserted-by":"crossref","first-page":"2075","DOI":"10.1007\/s00415-019-09363-4","article-title":"An update on genetic frontotemporal dementia","volume":"266","author":"Greaves","year":"2019","journal-title":"J Neurol"},{"key":"10.1007\/s13311-021-01152-0_bib78","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1007\/s00401-019-02066-0","article-title":"The TMEM106B FTLD-protective variant, rs1990621, is also associated with increased neuronal proportion","volume":"139","author":"Li","year":"2020","journal-title":"Acta Neuropathol"},{"key":"10.1007\/s13311-021-01152-0_bib79","doi-asserted-by":"crossref","unstructured":"Bellenguez C, K\u00fc\u00e7\u00fckali F, Jansen I, Andrade V, Moreno-Grau S, Amin N, et al. New insights on the genetic etiology of Alzheimer's and related dementia. medRxiv preprint 2020.10.01.20200659.\u00a0https:\/\/doi.org\/10.1101\/2020.10.01.20200659. Nat Genet 2022; in press.","DOI":"10.1101\/2020.10.01.20200659"},{"key":"10.1007\/s13311-021-01152-0_bib80","doi-asserted-by":"crossref","unstructured":"Naj AC, Leonenko G, Jian X, Grenier-Boley B, Dalmasso C, Bellenguez C, et al. Genome-wide meta-analysis of late-onset Alzheimer's disease using rare variant imputation in 65,602 subjects identifies novel rare variant locus NCK2: The International Genomics of Alzheimer's Project (IGAP). medRxiv preprint 2021.03.14.21253553.\u00a0https:\/\/doi.org\/10.1101\/2021.03.14.21253553.","DOI":"10.1101\/2021.03.14.21253553"},{"key":"10.1007\/s13311-021-01152-0_bib81","doi-asserted-by":"crossref","first-page":"108","DOI":"10.1038\/mp.2015.23","article-title":"A novel Alzheimer disease locus located near the gene coding tau protein","volume":"21","author":"Jun","year":"2016","journal-title":"Mol Psychiatry"},{"key":"10.1007\/s13311-021-01152-0_bib82","doi-asserted-by":"crossref","first-page":"1099","DOI":"10.1001\/jamaneurol.2019.1456","article-title":"Analysis of whole-exome sequencing data for Alzheimer disease stratified by APOE genotype","volume":"76","author":"Ma","year":"2019","journal-title":"JAMA Neurol"},{"key":"10.1007\/s13311-021-01152-0_bib83","doi-asserted-by":"crossref","first-page":"1553","DOI":"10.3233\/JAD-200037","article-title":"Whole-exome sequencing analysis of Alzheimer's disease in non-APOE*4 carriers","volume":"76","author":"Fan","year":"2020","journal-title":"J Alzheimer Dis"},{"key":"10.1007\/s13311-021-01152-0_bib84","doi-asserted-by":"crossref","first-page":"1483","DOI":"10.1001\/jama.2013.2973","article-title":"Variants in the ATP-binding cassette transporter (ABCA7), apolipoprotein E \u03f54, and the risk of late-onset Alzheimer disease in African Americans","volume":"309","author":"Reitz","year":"2013","journal-title":"JAMA"},{"key":"10.1007\/s13311-021-01152-0_bib85","doi-asserted-by":"crossref","first-page":"102","DOI":"10.1001\/jamaneurol.2020.3536","article-title":"Novel Alzheimer disease risk loci and pathways in African American individuals using the African Genome Resources Panel: A meta-analysis","volume":"78","author":"Kunkle","year":"2021","journal-title":"JAMA Neurol"},{"key":"10.1007\/s13311-021-01152-0_bib86","doi-asserted-by":"crossref","first-page":"609","DOI":"10.1016\/j.jalz.2014.06.010","article-title":"Two rare AKAP9 variants are associated with Alzheimer's disease in African Americans","volume":"10","author":"Logue","year":"2014","journal-title":"Alzheimers Dement"},{"key":"10.1007\/s13311-021-01152-0_bib87","doi-asserted-by":"crossref","first-page":"119","DOI":"10.1016\/j.jalz.2016.09.002","article-title":"Two novel loci, COBL and SLC10A2, for Alzheimer's disease in African Americans","volume":"13","author":"Mez","year":"2017","journal-title":"Alzheimers Dement"},{"key":"10.1007\/s13311-021-01152-0_bib88","doi-asserted-by":"crossref","unstructured":"Reitz C, Mayeux R; Alzheimer's Disease Genetics Consortium. TREM2 and neurodegenerative disease. N Engl J Med. 2013;369:1564\u20131565.","DOI":"10.1056\/NEJMc1306509"},{"issue":"1","key":"10.1007\/s13311-021-01152-0_bib89","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1186\/s13024-015-0016-9","article-title":"TREM2 is associated with increased risk for Alzheimer's disease in African Americans","volume":"10","author":"Jin","year":"2015","journal-title":"Mol Neurodegener"},{"key":"10.1007\/s13311-021-01152-0_bib90","doi-asserted-by":"crossref","first-page":"1697","DOI":"10.1073\/pnas.1715554115","article-title":"Identification of genetic risk factors in the Chinese population implicates a role of immune system in Alzheimer's disease pathogenesis","volume":"115","author":"Zhou","year":"2018","journal-title":"Proc Natl Acad Sci USA"},{"key":"10.1007\/s13311-021-01152-0_bib91","doi-asserted-by":"crossref","first-page":"379","DOI":"10.1007\/s12035-014-9015-z","article-title":"Validating GWAS-identified risk loci for Alzheimer's disease in Han Chinese populations","volume":"53","author":"Wang","year":"2016","journal-title":"Mol Neurobiol"},{"issue":"217","key":"10.1007\/s13311-021-01152-0_bib92","first-page":"e1","article-title":"A rare coding variant in TREM2 increases risk for Alzheimer's disease in Han Chinese","volume":"42","author":"Jiang","year":"2016","journal-title":"Neurobiol Aging"},{"key":"10.1007\/s13311-021-01152-0_bib93","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1038\/s41398-021-01272-3","article-title":"Ethnic and trans-ethnic genome-wide association studies identify new loci influencing Japanese Alzheimer's disease risk","volume":"11","author":"Shigemizu","year":"2021","journal-title":"Transl Psychiatry"},{"key":"10.1007\/s13311-021-01152-0_bib94","doi-asserted-by":"crossref","first-page":"989","DOI":"10.1038\/ng.3043","article-title":"Large-scale meta-analysis of genome-wide association data identifies six new risk loci for Parkinson's disease","volume":"46","author":"Nalls","year":"2014","journal-title":"Nat Genet"},{"key":"10.1007\/s13311-021-01152-0_bib95","doi-asserted-by":"crossref","first-page":"20","DOI":"10.3389\/fnagi.2017.00020","article-title":"Genetic determinants of Parkinson's disease: can they help to stratify the patients based on the underlying molecular defect?","volume":"9","author":"Redensek","year":"2017","journal-title":"Front Aging Neurosci"},{"key":"10.1007\/s13311-021-01152-0_bib96","unstructured":"Diabetes Genet. Replication Meta-Anal. (DIAGRAM) Consort., Asian Genet. Epidemiol. Netw. Type 2 Diabetes (AGEN-T2D) Consort., South Asian Type 2 Diabetes (SAT2D) Consort., Mex. Am. Type 2 Diabetes (MAT2D) Consort., Type 2 Diabetes Genet. Explor.Next-Gener. Seq. Multi-Ethnic Samples (T2D-GENES) Consort., et al. Genome-wide trans-ancestry meta-analysis provides insight into the genetic architecture of type 2 diabetes susceptibility. Nat Genet 2014; 46:234\u2013244."},{"key":"10.1007\/s13311-021-01152-0_bib97","doi-asserted-by":"crossref","first-page":"2384","DOI":"10.1007\/s00125-017-4405-1","article-title":"Transethnic insight into the genetics of glycaemic traits: fine-mapping results from the Population Architecture Using Genomics and Epidemiology PAGE) consortium","volume":"60","author":"Bien","year":"2017","journal-title":"Diabetologia"},{"key":"10.1007\/s13311-021-01152-0_bib98","doi-asserted-by":"crossref","first-page":"514","DOI":"10.1038\/s41586-019-1310-4","article-title":"Genetic analyses of diverse populations improve discovery for complex traits","volume":"570","author":"Wojcik","year":"2019","journal-title":"Nature"},{"key":"10.1007\/s13311-021-01152-0_bib99","doi-asserted-by":"crossref","unstructured":"Bien SA, Wojcik GL, Hodonsky CJ, Gignoux CR, Cheng I, Matise TC et al. The future of genomic studies must be globally representative: Perspectives from PAGE. Annu Rev Genom Hum Genet 2109; 20:181\u2013200.","DOI":"10.1146\/annurev-genom-091416-035517"},{"key":"10.1007\/s13311-021-01152-0_bib100","doi-asserted-by":"crossref","first-page":"727","DOI":"10.1016\/j.jalz.2016.12.012","article-title":"Transethnic genome-wide scan identifies novel Alzheimer's disease loci","volume":"13","author":"Jun","year":"2017","journal-title":"Alzheimer's Dementia"},{"key":"10.1007\/s13311-021-01152-0_bib101","doi-asserted-by":"crossref","first-page":"520","DOI":"10.1038\/s41576-019-0144-0","article-title":"Genomics of disease risk in globally diverse populations","volume":"20","author":"Gurdasani","year":"2019","journal-title":"Nat Rev Genet"},{"key":"10.1007\/s13311-021-01152-0_bib102","doi-asserted-by":"crossref","first-page":"314","DOI":"10.1038\/nrg2316","article-title":"The road to genome-wide association studies","volume":"9","author":"Kruglyak","year":"2008","journal-title":"Nat Rev Genet"},{"key":"10.1007\/s13311-021-01152-0_bib103","unstructured":"Bis JC, Jian X, Kunkle BW, Chen Y, Hamilton-Nelson KL, Bush WS, et al. Whole exome sequencing study identifies novel rare and common Alzheimer's-Associated variants involved in immune response and transcriptional regulation. Mol Psychiatry 2020; 25:1859\u20131875. Published online 14 August 2018."},{"key":"10.1007\/s13311-021-01152-0_bib104","doi-asserted-by":"crossref","first-page":"1560","DOI":"10.1038\/ng.3968","article-title":"Analysis commons, a team approach to discovery in a big-data environment for genetic epidemiology","volume":"49","author":"Brody","year":"2017","journal-title":"Nat Genet"},{"key":"10.1007\/s13311-021-01152-0_bib105","doi-asserted-by":"crossref","first-page":"851","DOI":"10.1038\/nature06258","article-title":"A second generation human haplotype map of over 3 million SNPs","volume":"449","author":"The International HapMap Consortium","year":"2007","journal-title":"Nature"},{"key":"10.1007\/s13311-021-01152-0_bib106","doi-asserted-by":"crossref","first-page":"1699","DOI":"10.1056\/NEJMp0808934","article-title":"Genomewide association studies\u2013illuminating biologic pathways","volume":"360","author":"Hirschhorn","year":"2009","journal-title":"N Engl J Med"},{"key":"10.1007\/s13311-021-01152-0_bib107","doi-asserted-by":"crossref","unstructured":"Beecham GW, Bis JC, Martin ER, Choi SH, DeStefano AL, van Duijn CM, et al. The Alzheimer's Disease Sequencing Project: Study design and sample selection. Neurol Genet 2017; 3(5):e194.","DOI":"10.1212\/NXG.0000000000000194"},{"key":"10.1007\/s13311-021-01152-0_bib108","doi-asserted-by":"crossref","first-page":"1066","DOI":"10.1074\/jbc.M109.044321","article-title":"Inherent anti-amyloidogenic activity of human immunoglobulin gamma heavy chains","volume":"285","author":"Adekar","year":"2010","journal-title":"J Bio Chem"},{"key":"10.1007\/s13311-021-01152-0_bib109","doi-asserted-by":"crossref","first-page":"1190","DOI":"10.1126\/science.1222794","article-title":"Systematic localization of common disease-associated variation in regulatory DNA","volume":"337","author":"Maurano","year":"2012","journal-title":"Science"},{"key":"10.1007\/s13311-021-01152-0_bib110","doi-asserted-by":"crossref","first-page":"337","DOI":"10.1038\/nature13835","article-title":"Genetic and epigenetic fine mapping of causal autoimmune disease variants","volume":"518","author":"Farh","year":"2015","journal-title":"Nature"},{"key":"10.1007\/s13311-021-01152-0_bib111","doi-asserted-by":"crossref","first-page":"5473","DOI":"10.1073\/pnas.1418631112","article-title":"Whole-genome sequencing is more powerful than whole-exome sequencing for detecting exome variants","volume":"112","author":"Belkadi","year":"2015","journal-title":"Proc Natl Acad Sci USA"},{"key":"10.1007\/s13311-021-01152-0_bib112","doi-asserted-by":"crossref","first-page":"1509","DOI":"10.1002\/alz.12319","article-title":"Whole-genome sequencing reveals new Alzheimer's disease-associated rare variants in loci related to synaptic function and neuronal development","volume":"17","author":"Prokopenko","year":"2021","journal-title":"Alzheimers Dement"},{"key":"10.1007\/s13311-021-01152-0_bib113","doi-asserted-by":"crossref","first-page":"707","DOI":"10.1016\/j.cell.2013.03.030","article-title":"Integrated systems approach identifies genetic nodes and networks in late-onset Alzheimer's disease","volume":"153","author":"Zhang","year":"2013","journal-title":"Cell"},{"key":"10.1007\/s13311-021-01152-0_bib114","doi-asserted-by":"crossref","first-page":"332","DOI":"10.1038\/s41586-019-1195-2","article-title":"Single-cell transcriptomic analysis of Alzheimer's disease","volume":"570","author":"Mathys","year":"2019","journal-title":"Nature"},{"key":"10.1007\/s13311-021-01152-0_bib115","doi-asserted-by":"crossref","first-page":"2087","DOI":"10.1038\/s41593-019-0539-4","article-title":"A single cell brain atlas in human Alzheimer's disease","volume":"22","author":"Grubman","year":"2019","journal-title":"Nat Neurosci"},{"key":"10.1007\/s13311-021-01152-0_bib116","unstructured":"International Genomics of Alzheimer's Disease Consortium (IGAP). Convergent genetic and expression data implicate immunity in Alzheimer's disease. Azheimers Dement 2015;11:658\u2013671."},{"key":"10.1007\/s13311-021-01152-0_bib117","doi-asserted-by":"crossref","first-page":"1134","DOI":"10.1126\/science.aay0793","article-title":"Brain cell type\u2013specific enhancer\u2013promoter interactome maps and disease-risk association","volume":"366","author":"Nott","year":"2019","journal-title":"Science"},{"key":"10.1007\/s13311-021-01152-0_bib118","doi-asserted-by":"crossref","unstructured":"Gerring ZF, Gamazon ER, White A, Derks EM. Integrative network-based analysis reveals gene networks and novel drug repositioning candidates for Alzheimer disease. Neurol Genet 2021; 7:e622.","DOI":"10.1212\/NXG.0000000000000622"},{"key":"10.1007\/s13311-021-01152-0_bib119","doi-asserted-by":"crossref","unstructured":"Porcu E, Rueger S, Lepik K, eQTLGen Consortium, BIOS Consortium, Santoni FA, et al. Mendelian randomization integrating GWAS and eQTL data reveals genetic determinants of complex and clinical traits. Nat Commun 2019; 10: 3300.","DOI":"10.1101\/377267"},{"key":"10.1007\/s13311-021-01152-0_bib120","doi-asserted-by":"crossref","first-page":"717","DOI":"10.1016\/j.ajhg.2018.04.002","article-title":"The post-GWAS era: From association to function","volume":"102","author":"Gallagher","year":"2018","journal-title":"Am J Hum Genet"},{"key":"10.1007\/s13311-021-01152-0_bib121","doi-asserted-by":"crossref","first-page":"445","DOI":"10.1038\/ng.3246","article-title":"Loss-of-function variants in ABCA7 confer risk of Alzheimer's disease","volume":"47","author":"Steinberg","year":"2015","journal-title":"Nat Genet"},{"key":"10.1007\/s13311-021-01152-0_bib122","doi-asserted-by":"crossref","first-page":"9391","DOI":"10.1073\/pnas.0802679105","article-title":"MEF2C, a transcription factor that facilitates learning and memory by negative regulation of synapse numbers and function","volume":"105","author":"Barbosa","year":"2008","journal-title":"Proc Natl Acad Sci USA"},{"key":"10.1007\/s13311-021-01152-0_bib123","doi-asserted-by":"crossref","first-page":"861","DOI":"10.1038\/s41588-021-00875-2","article-title":"A map of transcriptional heterogeneity and regulatory variation in human microglia","volume":"53","author":"Young","year":"2021","journal-title":"Nat Genet"},{"key":"10.1007\/s13311-021-01152-0_bib124","doi-asserted-by":"crossref","unstructured":"Corces MR, Shcherbina A, Kundu S, Gloudemans MJ. Fr\u00e9sard L, Granja JM, et al. Single-cell epigenomic analyses implicate candidate causal variants at inherited risk loci for Alzheimer's and Parkinson's diseases. Nat Genet 2020; 52:1158\u20131168.","DOI":"10.1038\/s41588-020-00721-x"},{"key":"10.1007\/s13311-021-01152-0_bib125","doi-asserted-by":"crossref","unstructured":"Novikova G, Kapoor H, TCW J, Abud EM, Efthymiou AG, Chen SX, et al. Integration of Alzheimer's disease genetics and myeloid genomics identifies disease risk regulatory elements and genes. Nat Commun 2021; 12:1610.","DOI":"10.1038\/s41467-021-21823-y"},{"key":"10.1007\/s13311-021-01152-0_bib126","doi-asserted-by":"crossref","first-page":"626","DOI":"10.1038\/s41588-020-0625-2","article-title":"Quantifying genetic effects on disease mediated by assayed gene expression levels","volume":"52","author":"Yao","year":"2020","journal-title":"Nat Genet"},{"key":"10.1007\/s13311-021-01152-0_bib127","doi-asserted-by":"crossref","first-page":"1091","DOI":"10.1016\/S1474-4422(19)30320-5","article-title":"Identification of novel risk loci, causal insights, and heritable risk for Parkinson's disease: a meta-analysis of genome-wide association studies","volume":"18","author":"Nalls","year":"2019","journal-title":"Lancet Neurol"},{"key":"10.1007\/s13311-021-01152-0_bib128","doi-asserted-by":"crossref","first-page":"1670","DOI":"10.1038\/s41588-019-0512-x","article-title":"Comparative genetic architectures of schizophrenia in East Asian and European populations","volume":"51","author":"Lam","year":"2019","journal-title":"Nat Genet"},{"key":"10.1007\/s13311-021-01152-0_bib129","doi-asserted-by":"crossref","first-page":"2098","DOI":"10.1038\/s41467-018-04362-x","article-title":"Study of 300,486 individuals identifies 148 independent genetic loci influencing general cognitive function","volume":"9","author":"Davies","year":"2018","journal-title":"Nat Commun"},{"key":"10.1007\/s13311-021-01152-0_bib130","doi-asserted-by":"crossref","first-page":"3673","DOI":"10.1093\/brain\/awv268","article-title":"Common polygenic variation enhances risk prediction for Alzheimer's disease","volume":"138","author":"Escott-Price","year":"2015","journal-title":"Brain"},{"key":"10.1007\/s13311-021-01152-0_bib131","doi-asserted-by":"crossref","first-page":"1318","DOI":"10.1038\/s41588-018-0193-x","article-title":"Estimation of complex effect size distributions using summary-level statistics from genome-wide association studies across 32 complex traits","volume":"50","author":"Zhang","year":"2018","journal-title":"Nat Genet"},{"key":"10.1007\/s13311-021-01152-0_bib132","doi-asserted-by":"crossref","first-page":"4799","DOI":"10.1038\/s41467-020-18534-1","article-title":"Risk prediction of late-onset Alzheimer's disease implies an oligogenic architecture","volume":"11","author":"Zhang","year":"2020","journal-title":"Nat Commun"},{"key":"10.1007\/s13311-021-01152-0_bib133","doi-asserted-by":"crossref","unstructured":"Holland D, Frei O, Desikan R, Fan C-C, Shadrin AA, Smeland OB, et al. The genetic architecture of human complex phenotypes is modulated by linkage disequilibrium and heterozygosity. Genetics 2021; 217:iyaa046.","DOI":"10.1093\/genetics\/iyaa046"},{"key":"10.1007\/s13311-021-01152-0_bib134","doi-asserted-by":"crossref","first-page":"839","DOI":"10.1007\/s00401-017-1685-y","article-title":"Genome-wide association study identifies four novel loci associated with Alzheimer's endophenotypes and disease modifiers","volume":"133","author":"Deming","year":"2017","journal-title":"Acta Neuropathol"},{"key":"10.1007\/s13311-021-01152-0_bib135","doi-asserted-by":"crossref","first-page":"309","DOI":"10.1038\/s41380-018-0246-7","article-title":"Genome-wide association study of brain amyloid deposition as measured by Pittsburgh Compound-B (PiB)-PET imaging","volume":"26","author":"Yan","year":"2021","journal-title":"Mol Psychiatry"},{"key":"10.1007\/s13311-021-01152-0_bib136","doi-asserted-by":"crossref","first-page":"1288","DOI":"10.1001\/jamaneurol.2020.1760","article-title":"Association between common variants in RBFOX1, an RNA-binding protein, and brain amyloidosis in early and preclinical Alzheimer disease","volume":"77","author":"Raghavan","year":"2020","journal-title":"JAMA Neurol"},{"key":"10.1007\/s13311-021-01152-0_bib137","doi-asserted-by":"crossref","unstructured":"Damotte V, van der Lee SJ, Chouraki V, Grenier-Boley B, Simino J, Adams H, et al. Plasma amyloid \u03b2 levels are driven by genetic variants near APOEBACE1APPPSEN2: A genome-wide association study in over 12,000 non-demented participants. Alzheimers Dement 2021.\u00a0https:\/\/doi.org\/10.1002\/alz.12333. Online ahead of print.","DOI":"10.1002\/alz.12333"},{"issue":"22","key":"10.1007\/s13311-021-01152-0_bib138","doi-asserted-by":"crossref","first-page":"657","DOI":"10.21037\/atm.2019.10.66","article-title":"Genome-wide association study of cerebrospinal fluid neurofilament light levels in non-demented elders","volume":"7","author":"Niu","year":"2019","journal-title":"Ann Transl Med"},{"key":"10.1007\/s13311-021-01152-0_bib139","doi-asserted-by":"crossref","first-page":"4521","DOI":"10.18632\/aging.102066","article-title":"Genome-wide association study identifies CD1A associated with rate of increase in plasma neurofilament light in non-demented elders","volume":"11","author":"Wang","year":"2019","journal-title":"Aging (Albany NY)"},{"key":"10.1007\/s13311-021-01152-0_bib140","doi-asserted-by":"crossref","unstructured":"Beecham GW, Hamilton K, Naj AC, Martin ER, Huentelman M, Myers AJ, et al. Genome-wide association meta-analysis of neuropathologic features of Alzheimer's disease and related dementias. PLoS Genet 2014; 10(9):e1004606.","DOI":"10.1371\/journal.pgen.1004867"},{"key":"10.1007\/s13311-021-01152-0_bib141","doi-asserted-by":"crossref","first-page":"2561","DOI":"10.1093\/brain\/awaa209","article-title":"Genetic variants and functional pathways associated with resilience to Alzheimer's disease","volume":"143","author":"Dumitrescu","year":"2020","journal-title":"Brain"},{"key":"10.1007\/s13311-021-01152-0_bib142","doi-asserted-by":"crossref","unstructured":"DeMichele-Sweet MAA, Klei L, Creese B, Harwood JC, Weamer EA, McClain L, et al. Genome-wide association identifies the first risk loci for psychosis in Alzheimer disease. Mol Psychiatry 2021.\u00a0https:\/\/doi.org\/10.1038\/s41380-021-01152-8. Online ahead of print.","DOI":"10.1038\/s41380-021-01152-8"},{"key":"10.1007\/s13311-021-01152-0_bib143","doi-asserted-by":"crossref","first-page":"1340","DOI":"10.1038\/mp.2011.135","article-title":"Genome-wide association analysis of age-at-onset in Alzheimer's disease","volume":"17","author":"Kamboh","year":"2012","journal-title":"Mol Psychiatry."},{"key":"10.1007\/s13311-021-01152-0_bib144","doi-asserted-by":"crossref","first-page":"1394","DOI":"10.1001\/jamaneurol.2014.1491","article-title":"Effects of multiple genetic loci on age at onset in late-onset Alzheimer disease: a genome-wide association study","volume":"71","author":"Naj","year":"2014","journal-title":"JAMA Neurol"},{"key":"10.1007\/s13311-021-01152-0_bib145","doi-asserted-by":"crossref","unstructured":"Huang KL, Marcora E, Pimenova AA, Di Narzo AF, Kapoor M, Jin SCA, et al. A common haplotype lowers PU.1 expression in myeloid cells and delays onset of Alzheimer's disease. Nat Neurosci 2017; 20:1052\u20131061.","DOI":"10.1038\/nn.4587"},{"key":"10.1007\/s13311-021-01152-0_bib146","doi-asserted-by":"crossref","first-page":"133","DOI":"10.1007\/s40142-018-0155-8","article-title":"A brief synopsis on the genetics of Alzheimer's disease","volume":"6","author":"Kamboh","year":"2018","journal-title":"Curr Genet Med Rep"},{"key":"10.1007\/s13311-021-01152-0_bib147","doi-asserted-by":"crossref","first-page":"4831","DOI":"10.1172\/JCI137040","article-title":"Tau is not necessary for amyloid-beta-induced synaptic and memory impairments","volume":"130","author":"Puzzo","year":"2020","journal-title":"J Clin Invest"},{"key":"10.1007\/s13311-021-01152-0_bib148","doi-asserted-by":"crossref","unstructured":"Pickett EK, Herrmann AG, McQueen J, Abt K, Dando O, Tulloch J, et al. Amyloid beta and tau cooperate to cause reversible behavioral and transcriptional deficits in a model of Alzheimer's disease. Cell reports 2019; 29:3592\u2013604 e5.","DOI":"10.1016\/j.celrep.2019.11.044"},{"issue":"s1","key":"10.1007\/s13311-021-01152-0_bib149","doi-asserted-by":"crossref","first-page":"S611","DOI":"10.3233\/JAD-179935","article-title":"Role of Amyloid-beta and Tau proteins in Alzheimer's disease: Confuting the amyloid cascade","volume":"64","author":"Gulisano","year":"2018","journal-title":"J Alzheimer's Dis"},{"key":"10.1007\/s13311-021-01152-0_bib150","doi-asserted-by":"crossref","first-page":"309","DOI":"10.1038\/d41586-021-01546-2","article-title":"Landmark Alzheimer's drug approval confounds research community","volume":"594","author":"Mullard","year":"2021","journal-title":"Nature"},{"key":"10.1007\/s13311-021-01152-0_bib151","doi-asserted-by":"crossref","unstructured":"Walsh S, Merrick R, Milne R, Brayne C. Aducanumab for Alzheimer's disease? BMJ 2021; 374:n1682.","DOI":"10.1136\/bmj.n1682"}],"container-title":["Neurotherapeutics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s13311-021-01152-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s13311-021-01152-0\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1878747923001605?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1878747923001605?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s13311-021-01152-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,30]],"date-time":"2025-10-30T06:41:49Z","timestamp":1761806509000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1878747923001605"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,1]]},"references-count":151,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2022,1]]}},"alternative-id":["S1878747923001605"],"URL":"https:\/\/doi.org\/10.1007\/s13311-021-01152-0","relation":{},"ISSN":["1878-7479"],"issn-type":[{"value":"1878-7479","type":"print"}],"subject":[],"published":{"date-parts":[[2022,1]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Genomics and Functional Genomics of Alzheimer's Disease","name":"articletitle","label":"Article Title"},{"value":"Neurotherapeutics","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1007\/s13311-021-01152-0","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2023 The authors. Published by Elsevier B.V. All rights reserved.","name":"copyright","label":"Copyright"}]}}